The young age (<40), the negativity of the estrogen receptors (ER), the overexpression of HER2, the tumor size, the lymph–vascular invasion, the lymph nodes involvement and the proximity of the lesion to the nipple–areola complex, the high grading are risk factors for relapses [29]. The gene discussed is ERBB2; the disease is neoplasm.